updated 1/21/2011 11:15:51 PM ET 2011-01-22T04:15:51

New York, Jan. 21, 2011 (GLOBE NEWSWIRE) -- Maurice Ross, partner at Barton, Barton & Plotkin LLP was recently a guest on LegalMinds.TV where he was invited to share his insights about the impact of intellectual property rights on valuations for public companies.

The interview, which is part of the recently launched LegalMinds/NASDAQ Securities & Capital Market Series, can be viewed at the LegalMinds.TV website ( http://legalminds.tv/nasdaq/ross-ip ) and will also soon be accessible on SocialStream@NASDAQ ( http://social.nasdaqomx.com ). It will also be featured in it's entirety in the upcoming issue of LegalMinds™ digital magazine ( http://www.legalmindsmagazine.com.)

During the interview, which was filmed at the NASDAQ MarketSite Broadcast Studio in Times Square, Ross discussed how significant changes in the regulatory environment will continue to have an impact on intellectual property rights and the impact on stock prices, director liability, M&A activity and litigation costs.

"I’m constantly amazed by the extent to which investment bankers advising large companies or executives at those companies fail to realize the importance of conducting due diligence on intellectual property issues before entering into a transaction," Ross said.

"From a defensive point of view, there are often competitors who have acquired or may acquire intellectual property rights that can actually put a company out of business, depress profits or interfere with its ability to market a product or service.

"The other issue is whether the company is doing a sufficient job to obtain, procure and enforce its own intellectual property rights -- does the company have a realistic understanding of the value of the patents, trademarks and other intellectual property rights that are owned?"

Ross also discussed other legal issues which can have an impact on a company’s IP portfolio, such as charges of "inequitable conduct" and recent opinions about "inducement of infringement."

Maurice Ross is a Partner at Barton, Barton & Plotkin specializing in Commercial, Intellectual Property and Patent Litigation. Ross has served as lead trial and appellate counsel in high-stakes patent and intellectual property litigation involving major pharmaceutical and biotechnology companies. He is also recognized as an expert on disputes relating to attorney-client privilege and work product immunity, and he has been counsel of record in landmark decisions in this area. More recently, Ross has advised domestic and international clients concerning how to successfully and efficiently address the challenges and burdens imposed by electronic discovery. Ross has published frequently in the areas of intellectual property, patent law and the attorney-client privilege.

About Barton, Barton & Plotkin LLP

Founded in 1959, Barton Barton & Plotkin is a full service law firm with offices in New York City. Its attorneys are seasoned professionals who are consistently rated among the top lawyers in the country. For more information about BB&P, or for issues pertaining to intellectual property, commercial or patent litigation visit http://www.bartonesq.com .

CONTACT: Maurice Ross
         Barton, Barton & Plotkin LLP
         Bruce Colwin
         LegalMinds Media LLC

© Copyright 2012, GlobeNewswire, Inc. All Rights Reserved


Discussion comments


Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments

Data: Latest rates in the US

Home equity rates View rates in your area
Home equity type Today +/- Chart
$30K HELOC FICO 3.79%
$30K home equity loan FICO 4.99%
$75K home equity loan FICO 4.69%
Credit card rates View more rates
Card type Today +/- Last Week
Low Interest Cards 13.83%
Cash Back Cards 17.80%
Rewards Cards 17.18%
Source: Bankrate.com